World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03347916
Date of registration: 14/11/2017
Prospective Registration: No
Primary sponsor: Kuwait Specialized Eye Center
Public title: Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation
Scientific title: The Role of Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation and Delirium in Children After Strabismus Surgery: A Prospective Randomized Double-blind Study
Date of first enrolment: January 5, 2017
Target sample size: 75
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03347916
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Kuwait
Contacts
Name:     Nicolas Abou chaar, MSSc
Address: 
Telephone: +96597714558
Email: nicolas.abouchaar@gmail.com
Affiliation: 
Name:     Ahmed A. BAdawy, MD
Address: 
Telephone: +96597700293
Email: dr.ahmedbadawy545@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- pediatric patients (2-6 years old), with an American society of Anesthegiologists
physical status (ASA) I-II who were undergoing strabismus surgery (for more than one
muscle)

Exclusion Criteria:

- failure to obtain consent, mental retardation or developmental delay, epilepsy,
psychiatric or neurological diseases that impair communication, current use of
gabapentin, psychotropic or opioids.



Age minimum: 2 Years
Age maximum: 6 Years
Gender: All
Health Condition(s) or Problem(s) studied
Emergence Agitation After Desflurane Anesthesia
Intervention(s)
Drug: Strawberry juice as (placebo)
Drug: Gabapentin Oral Solution [Neurontin]
Primary Outcome(s)
emergence agitation incidence and scores [Time Frame: through study completion, an average of 1 year]
Secondary Outcome(s)
duration of emergence [Time Frame: through study completion, an average of 1 year]
Secondary ID(s)
kuwaiteyecenter01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history